| TAH Drug Code | IVAR |
|---|---|
| Indications | Active immunisation against varicella of healthy infants from 12 months onwards, susceptible high-risk patients & their susceptible healthy close contacts. |
| Dosing | SC, 0.5 mL, 12 months-12 years 2 doses administered 3 months apart. > or = 13 years 2 doses administered 4-8 weeks apart. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Pregnancy. Acute febrile illness. Total lymphocyte count < 1200/mm3. Hypersensitivity to neomycin. |
| Adverse Effects | Common: Injection site disorder (19.3-32.5%), Rash, Varicella-like (0.5-5.5%), Fever (9.5-66.8%) Serious: Stevens-Johnson syndrome, Toxic epidermal necrolysis, Thrombocytopenic purpura, Anaphylaxis, Herpes zoster ophthalmicus, Encephalitis, Febrile seizure (Less than 0.1%) |
| Pregnancy | Contraindicated |
| Lactation | Compatible |
| More Info | UpToDate |
| TAH Drug Code | IVAR2 |
|---|---|
| Indications | Active immunisation against varicella of healthy infants from 12 months onwards, susceptible high-risk patients & their susceptible healthy close contacts. |
| Dosing | SC, 0.5 mL, 12 months-12 years 2 doses administered 3 months apart. > or = 13 years 2 doses administered 4-8 weeks apart. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Pregnancy. Acute febrile illness. Total lymphocyte count < 1200/mm3. Hypersensitivity to neomycin. |
| Adverse Effects | Common: Injection site disorder (19.3-32.5%), Rash, Varicella-like (0.5-5.5%), Fever (9.5-66.8%) Serious: Stevens-Johnson syndrome, Toxic epidermal necrolysis, Thrombocytopenic purpura, Anaphylaxis, Herpes zoster ophthalmicus, Encephalitis, Febrile seizure (Less than 0.1%) |
| Pregnancy | Contraindicated |
| Lactation | Compatible |
| More Info | UpToDate |